Biolargo annual debt-to-assets ratio
2010
2011
2018
2019
2020
2021
2022
2023
2024
2025
Biolargo's debt-to-assets ratio was 0.42 for fiscal 2025.
View full Biolargo company overview| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.42 | 0.18 | +73.99% |
| 2024 | 2024-12-31 | 0.24 | 0.06 | +36.15% |
| 2023 | 2023-12-31 | 0.18 | −0.07 | −28.19% |
| 2022 | 2022-12-31 | 0.25 | −0.06 | −20.60% |
| 2021 | 2021-12-31 | 0.31 | −0.10 | −24.71% |
| 2020 | 2020-12-31 | 0.42 | −1.01 | −70.88% |
| 2019 | 2019-12-31 | 1.43 | 0.33 | +30.36% |
| 2018 | 2018-12-31 | 1.09 | — | — |
| 2011 | 2011-12-31 | 2.72 | −0.84 | −23.57% |
| 2010 | 2010-12-31 | 3.56 | — | — |
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.19 | 0.08 | +64.78% |
| Q1 2026 | 2026-03-31 | 0.16 | 0.02 | +17.05% |
| Q4 2025 | 2025-12-31 | 0.42 | 0.18 | +73.99% |
| Q3 2025 | 2025-09-30 | 0.17 | 0.05 | +37.45% |
| Q2 2025 | 2025-06-30 | 0.12 | −0.01 | −10.73% |
| Q1 2025 | 2025-03-31 | 0.14 | −0.01 | −7.28% |
| Q4 2024 | 2024-12-31 | 0.24 | 0.06 | +36.15% |
| Q3 2024 | 2024-09-30 | 0.13 | −0.05 | −28.54% |
| Q2 2024 | 2024-06-30 | 0.13 | −0.05 | −25.86% |
| Q1 2024 | 2024-03-31 | 0.15 | −0.04 | −19.59% |
| Q4 2023 | 2023-12-31 | 0.18 | −0.07 | −28.19% |
| Q3 2023 | 2023-09-30 | 0.18 | −0.11 | −37.45% |
| Q2 2023 | 2023-06-30 | 0.18 | −0.04 | −16.59% |
| Q1 2023 | 2023-03-31 | 0.18 | −0.04 | −19.50% |
| Q4 2022 | 2022-12-31 | 0.25 | −0.06 | −20.60% |
| Q3 2022 | 2022-09-30 | 0.28 | 0.13 | +89.50% |
| Q2 2022 | 2022-06-30 | 0.21 | 0.07 | +45.42% |
| Q1 2022 | 2022-03-31 | 0.23 | −0.01 | −3.60% |
| Q4 2021 | 2021-12-31 | 0.31 | −0.10 | −24.71% |
| Q3 2021 | 2021-09-30 | 0.15 | −0.48 | −76.30% |
| Q2 2021 | 2021-06-30 | 0.15 | −0.95 | −86.67% |
| Q1 2021 | 2021-03-31 | 0.23 | −1.37 | −85.38% |
| Q4 2020 | 2020-12-31 | 0.42 | −1.01 | −70.88% |
| Q3 2020 | 2020-09-30 | 0.63 | — | — |
| Q2 2020 | 2020-06-30 | 1.10 | −0.42 | −27.52% |
| Q1 2020 | 2020-03-31 | 1.61 | 0.24 | +17.77% |
| Q4 2019 | 2019-12-31 | 1.43 | 0.33 | +30.36% |
| Q2 2019 | 2019-06-30 | 1.51 | −0.24 | −13.71% |
| Q1 2019 | 2019-03-31 | 1.36 | — | — |
| Q4 2018 | 2018-12-31 | 1.09 | — | — |
| Q3 2018 | 2018-09-30 | 2.09 | — | — |
| Q2 2018 | 2018-06-30 | 1.75 | — | — |
| Q3 2012 | 2012-09-30 | 0.76 | −3.86 | −83.53% |
| Q2 2012 | 2012-06-30 | 0.65 | −3.63 | −84.86% |
| Q1 2012 | 2012-03-31 | 1.50 | — | — |
| Q4 2011 | 2011-12-31 | 2.72 | −0.84 | −23.57% |
| Q3 2011 | 2011-09-30 | 4.63 | — | — |
| Q2 2011 | 2011-06-30 | 4.28 | — | — |
| Q4 2010 | 2010-12-31 | 3.56 | — | — |
Over the last five fiscal years, Biolargo's debt-to-assets ratio increased from 0.42 to 0.42, a change of 0.01. The latest reported quarter, Q2 2026, shows 0.19.
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Biolargo source filings ↗